Your browser doesn't support javascript.
loading
Troglitazone, a PPAR agonist, inhibits human prostate cancer cell growth through inactivation of NFκB via suppression of GSK-3ß expression.
Ban, Jung Ok; Oh, Ju Hoon; Son, Seung Mo; Won, Dohee; Song, Ho Seub; Han, Sang Bae; Moon, Dong Cheul; Kang, Keon Wook; Song, Min Jong; Hong, Jin Tae.
Affiliation
  • Ban JO; College of Pharmacy and Medical Research Center, Chungbuk National University, Korea.
Cancer Biol Ther ; 12(4): 288-96, 2011 Aug 15.
Article in En | MEDLINE | ID: mdl-21613824
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Chromans / NF-kappa B / Glycogen Synthase Kinase 3 / Thiazolidinediones / PPAR gamma / Cell Proliferation Limits: Humans / Male Language: En Journal: Cancer Biol Ther Journal subject: NEOPLASIAS / TERAPEUTICA Year: 2011 Document type: Article Country of publication: Estados Unidos
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Chromans / NF-kappa B / Glycogen Synthase Kinase 3 / Thiazolidinediones / PPAR gamma / Cell Proliferation Limits: Humans / Male Language: En Journal: Cancer Biol Ther Journal subject: NEOPLASIAS / TERAPEUTICA Year: 2011 Document type: Article Country of publication: Estados Unidos